{{Drugbox
| Verifiedfields = changed
| verifiedrevid = 477514682
| IUPAC_name = Copolymer of bis(2-aminoethyl)amine and 2-(chloromethyl)oxirane
| image = Colestipol skeletal 2.svg
<!--Clinical data -->
| tradename = Colestid, Cholestabyl
| Drugs.com = {{drugs.com|monograph|colestipol-hydrochloride}}
| MedlinePlus = a682157
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_US = B
| pregnancy_category = 
| legal_AU = <!-- Unscheduled / S2 / S3 / S4 / S5 / S6 / S7 / S8 / S9 -->
| legal_CA = <!--             / Schedule I, II, III, IV, V, VI, VII, VIII -->
| legal_UK = <!-- GSL         / P       / POM / CD / Class A, B, C -->
| legal_US = Rx-only
| legal_status = 
| routes_of_administration = Oral ([[suspension (chemistry)|suspension]] or tablets)
<!--Pharmacokinetic data -->
| bioavailability = None
| protein_bound = 
| metabolism = 
| elimination_half-life = 
| excretion = Faeces, in complex with [[bile acid]]s
<!--Identifiers -->
| CAS_number_Ref = {{cascite|changed|CAS}}
| CAS_number = 26658-42-4
| CAS_supplemental = <br />{{CAS|37296-80-3}} ([[Hydrochloride|HCl]])
| ATC_prefix = C10
| ATC_suffix = AC02
| PubChem = 62816
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank = DB00375
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = K50N755924
| KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG = C06925
| ChEMBL_Ref = {{ebicite|correct|EBI}}
| ChEMBL = 1201678
| ChemSpiderID_Ref = {{chemspidercite|changed|chemspider}}
| ChemSpiderID = none
<!--Chemical data -->
| chemical_formula = (C<sub>4</sub>H<sub>10</sub>N<sub>3</sub>)<sub>m</sub>(C<sub>3</sub>H<sub>6</sub>O)<sub>n</sub>
}}
'''Colestipol''' (trade names '''Colestid''', '''Cholestabyl''') is a [[bile acid sequestrant]] used to lower blood [[cholesterol]], specifically [[low-density lipoprotein]] (LDL).<ref>{{Cite journal 
| last1 = Handelsman | first1 = Y. 
| doi = 10.2337/dc11-s237 
| title = Role of Bile Acid Sequestrants in the Treatment of Type 2 Diabetes 
| journal = Diabetes Care 
| volume = 34 
| pages = S244–S250 
| year = 2011 
| pmid = 21525463 
| pmc = 
}}</ref><ref name="Drugs">Drugs.com: [http://www.drugs.com/monograph/colestipol-hydrochloride.html Colestipol Hydrochloride]</ref>  It is also used to reduce stool volume and frequency, and in the treatment of chronic diarrhea.<ref>http://www.medicinenet.com/colestipol/article.htm</ref>

Like [[cholestyramine]], colestipol works in the gut by trapping [[bile acid]]s and preventing them from being reabsorbed. This leads to decreased [[enterohepatic circulation|enterohepatic recirculation]] of bile acids, increased synthesis of new bile acids by the liver from cholesterol, decreased liver cholesterol, increased [[LDL receptor]] expression, and decreasing LDL in blood.<ref>{{Cite book|last1=Mutschler|first1=Ernst|last2=Schäfer-Korting|first2=Monika|title=Arzneimittelwirkungen|language=German|location=Stuttgart|publisher=Wissenschaftliche Verlagsgesellschaft|year=2001|edition=8|page=523|isbn=3-8047-1763-2}}</ref>

==Side effects==
The following notable side effects may occur:<ref name="Drugs" />
* [[Human gastrointestinal tract|gastrointestinal tract]] disturbances, especially (mild, occasionally severe) constipation
* sometimes increase in [[Very low-density lipoprotein|VLDL]]{{fact|date=January 2012}} and [[triglyceride]] synthesis

==Interactions==
Colestipol can bind to a number of drugs and nutrients in the gut and inhibit or delay their absorption. Such substances include:<ref name="Drugs" />
* [[thiazide diuretic]]s, [[furosemide]]
* [[gemfibrozil]]
* [[benzylpenicillin]], [[tetracycline]]
* [[digoxin]]
* lipid-soluble vitamins ([[Vitamin A|A]], [[Vitamin D|D]], [[Vitamin E|E]], [[Vitamin K|K]])

==Contraindications==
Colestipol is contraindicated in [[hypertriglyceridemia]] (high level of [[triglyceride]]s in the blood).{{fact|date=January 2012}}

==Chemistry==
Colestipol is a [[copolymer]] of [[diethylenetriamine]] (DETA) —or [[tetraethylenepentamine]] according to some sources<ref>Clinical Pharmacology: [http://www.clinicalpharmacology.com/apps/images/structures/001/colestip.gif Colestipol structure]</ref><ref>Beth Israel Deaconess Medical Center & Care Group: [http://home.caregroup.org/clinical/altmed/interactions/Images/Drugs/colestip.gif Colestipol structure] {{webarchive|url=https://web.archive.org/web/20101229060705/http://home.caregroup.org/clinical/altmed/interactions/Images/Drugs/colestip.gif |date=2010-12-29 }}</ref>— and [[epichlorohydrin]].<ref name="AustriaCodex">{{cite book|title=Austria-Codex|editor=Haberfeld, H|publisher=Österreichischer Apothekerverlag|location=Vienna|year=2009|edition=2009/2010|isbn=3-85200-196-X|language=German}}</ref><ref>{{cite book|title=Medizinische Chemie|page=433|last1=Steinhilber|first1=D|last2=Schubert-Zsilavecz|first2=M|last3=Roth|first3=HJ|publisher=Deutscher Apotheker Verlag|location=Stuttgart|year=2005|isbn=3-7692-3483-9|language=German}}</ref> The structure drawing (top right) shows the DETA moieties in blue and the epichlorohydrin moieties in red.
{|
|-
| [[File:Colestipol skeletal.svg|thumb|left|Alternative chemical structure, with [[tetraethylenepentamine]] instead of [[diethylenetriamine]]; formula (C<sub>8</sub>H<sub>18</sub>N<sub>5</sub>)<sub>m</sub>(C<sub>3</sub>H<sub>6</sub>O)<sub>n</sub>]]
| [[File:Diethylene triamine.png|thumb|left|The constituent DETA]]<br />[[File:Colestipol_constituents.png|thumb|left|The constituents [[tetraethylenepentamine]] (top) and [[epichlorohydrin]] (bottom)]]
|}

== Notes and references ==
{{reflist}}

{{Lipid modifying agents}}

[[Category:Bile acid sequestrants]]